anyone follow the last few trades at close today.
ya, with so much spam, why even
post. longterm holders, tell me where you post and i`ll
join. i`ve had numerous articles to post but why, spam
rules yahoo now.
I lived Chgo area, watched ABT grow for 40 years.
moved away, but still visit area. Always enjoy seeing
all the happy faces of the stockholders on the way to
and from work. They know ABT. If in the area drive by
and check it all out. Hold on to this, I know I will.
ABT is an excellent buy- and you indicate you
like its historic performance (not an indication of
future growth) and did some research- so why the fear of
a single earnings report- and a sale so soon after
buying?? These stocks are best as long term holdings. To
go in and out too soon- you pay top tax dollar- and
if you are downside- you lose capital- both bad.
This stock is not an instant money-maker- but should
give you good steady returns. It may?? be slightly
overvalued at this price- but a few years out- you should be
very happy- (my opinion). Hope this helps.
Your right it's not a pure Biotech play. I guess
I should have listed the reasons to be encouraged
about Abbott as well.
My main purpose of only
listing concerns was to reply to a earlier post from
someone wanting to know the pitfalls of this stock, if
In general, I think this is a good stock to own long
term. They pay a nice consistant dividend and they are
very diverse as you said. I think their recent
deficiencies in some areas have been made up in others.
Definately not a daytrading stock, however not a bad stock
to buy options on. Scale of 1 to 10, I give ABT an
Good to have some nonspamming dialog on this board for
I have held this stock many years and have been
duly rewarded both in price appreciation and in annual
dividend increases. Abbott is not a biotech stock as you
have labeled it. It is not a pharmaceutical pure play
either like Pfizer either. It is a diversified health
care manufacturing company that makes hospital
equipment, diagnostic tests, nutritional products as well as
pharmaceuticals. Abbott's drug pipeline has been weak and I feel
that the Alza purchase will help remedy this as well
as strategic alliances that Abbott has entered into
with other smaller companies. Abbott is a supreme
marketer of products and will be able to market these new
products etter than smaller companies. Another promising
future product is Uptima, a drug for erectile
disfunction that can be taken by persons with heart problems
that cannot take Viagra.
In down markets,
Abbott generally does not decrease as much as the pure
pharmaceuticals, but in up markets it has not tended to perform as
well. Contrary to you, I am optimistic about Abbott if
past performance is any indication of future success.
If you want to earn money hold on to your stock
for the long term. This is a solid company. Check the
share price vs time graph. Solid over the long haul. If
you want to day trade find a different stock.
My wife and I used to buy simulac for
$3/container. Now we buy same size container of Carnation brand
Abbott used to research,
develope and discover. Now they're playing follow the
Unproven new CEO. What is the new guys claim to fame,
besides putting in his time? What has he done take Abbott
to the next level. He needs to prove himself. It may
take a little time.
Finally, the stock has been
stagnant lately along with other Biotechs. Who knows when
this slump will end.
I'm new to ABT but I checked the insider trading.
Alot of the big guys are exercising their options and
holding rather than selling. This is usually good news.
No trades since April and those only a small percent
of the holdings.
What's your take on this?
MRK and PFE are also down from their highs. In
fact Pfizer is down 25% (ABT only 17.5%). This share
price decline is mainly due to sector rotation by
institutional investors. I don't believe it has anything to do
with a perceived earnings shortfall. Hold on to Abbott
for the long term.
I'm a new investor to ABT and I'm alittle
concerned regarding this stocks downward movement over the
last two months. When I review the historical
performance of ABT and look at the ratios etc., it looks to
be an excellent buy within the drug sector and
may-be even undervalued. However since I'm new at this
game I'm looking for some help from the board--is the
reason for ABT's recent decline because they are going
to miss their estimate? Should I sell my shares
before they announce later this week or hang-in?
help "pro/or/con will be most helpful.
They don't understand the concept of a discount
rate. I only briefly looked at what they said, but the
fact that they said they used the same discount rate
for ABT as they did for PFE tells me immediately that
they are clueless. I wouldn't be surprised if they use
the same discount rate for internet stocks.